-Livemint.com While the good news is that crop acreages are not hit, the bad news is that the cash crunch is impacting sales—if this lasts long, demand destruction can be severe The winter or rabi crop sowing has gathered pace after a setback. The past two readings from the ministry of agriculture show crop sowing growth of 4-8% from the year-ago levels. In the first week after demonetisation, sowing dropped 0.7%. Sowing has now...
More »SEARCH RESULT
Total Matching Records found : 4031
Demonetisation crushes green shoots in rural India -Rashmi Pratap
-The Hindu Business Line Rabi sowing down; sales of tractors and two-wheelers dip Mumbai: The demonetisation of high-value currency notes seems to have crushed the tender green shoots of economic recovery in rural India by choking off life-sustaining money supply and impeding the wheels of commerce from spinning. From FMCG firms to two-wheelers to tractor makers, companies had been looking forward to an increase in rural demand in the wake of an adequate...
More »Narendra Modi's crop insurance scheme has few takers -Sayantan Bera
-Livemint.com Only 23.6% of farmers enrolled for the scheme in 2016, against 22.2% in 2015 New Delhi: Despite setting an ambitious target to cover half of all farmers under crop insurance, the first season rollout of the Pradhan Mantri Fasal Bima Yojana (PMFBY) has been tepid. According to the agriculture ministry, during the kharif 2016 season beginning June this year, 32.6 million farmers enrolled under PMFBY. While that is a 6.3% rise in...
More »CAG flags tax breaks for companies
-The Hindu Report tabled in Parliament says Reliance gained Rs. 5,245 crore from the exemption. The Comptroller and Auditor-General (CAG) has castigated the Income-Tax Department for extending tax exemption amounting to hundreds of crores to several companies by inappropriately extending benefits available for infrastructure projects. In a report tabled in Parliament on Tuesday, the CAG said the biggest beneficiary was Reliance Industries Ltd. (RIL). “We noticed in eight cases in two States that the...
More »Generics vs big pharma, reloaded -Shamnad Basheer
-The Hindu The proposal to extend the time limit for State-level drug regulatory approvals from four to 10 years could hit the generics market In a scathing letter to the Government of India, the Indian Pharmaceutical Alliance (IPA) took issue with what it considered to be a backdoor extension for data exclusivity norms in the country. It pointed to the recent government proposal to change the four-year time limit for State-level drug...
More »
